Abstract: Apparatus, methods, and computer program products for wireless communication are provided. An example method may include transmitting, to a second network entity, a first indication of a diversity and a second indication of a first quantity of scheduled layers associated with the first network entity. The example method may further include transmitting, to the second network entity, a set of beamforming weights based on the indication of the diversity and the first quantity of scheduled layers.

Abstract: A bandgap tuneable p-GaN high electron mobility transistor (HEMT) having a structure stacked on a silicon carbide substrate. The device incorporates an indium nitride nucleation layer, followed by an aluminum nitride nucleation layer, and a first aluminum gallium nitride buffer layer. A gallium nitride channel layer is deposited on this stack, with an aluminum source and a drain contact at either end. The bandgap tuneable p-GaN HEMT includes a two-dimensional molybdenum disulfide layer over the channel, covered by a second AlGaN buffer layer. A p-type gallium nitride cap layer and a platinum gate contact complete the structure. This configuration facilitates bandgap tuning and strain engineering, enhancing electron mobility and density in the two-dimensional electron gas region, making it suitable for high-power and high-frequency applications.

Abstract: A secure inference over Deep Neural Networks (DNNs) using secure two-party computation to perform privacy-preserving machine learning. The secure inference uses a particular type of comparison that can be used as a building block for various layers in the DNN including, for example, ReLU activations and divisions. The comparison securely computes a Boolean share of a bit representing whether input value x is less than input value y, where x is held by a user of the DNN, and where y is held by a provider of the DNN. Each party computing system parses their input into leaf strings of multiple bits. This is much more efficient than if the leaf strings were individual bits. Accordingly, the secure inference described herein is more readily adapted for using in complex DNNs.

Abstract: An integrated circuit including a comparator having an enable signal input and an output and timing circuitry. The timing circuitry includes a first transistor having a control terminal, a second transistor having a control terminal, a first inverter having an input coupled to the control terminal of the second transistor and having an output coupled to the enable signal input, and a second inverter having an input coupled to the output of the comparator and having an output coupled to the control terminal of the first transistor.

Abstract: An example apparatus includes: controller circuitry configured to: provide switch signals to capacitive digital to analog converter (C-DAC) circuitry, the C-DAC circuitry including switches; configuring the switches into a third configuration begin an Auto Zero (AZ) phase with a third switch in a closed state; configuring the switches into a fourth configuration to repeat the transition of the third switch to the open state corresponding to a first configuration; configuring the switches into a fifth configuration to repeat the transition of a first switch and a second switch to the open state corresponding to a second configuration; configuring the switches into a sixth configuration to repeat the transition of the third switch to the closed state corresponding to a second configuration; and performing an AZ decision with the switches in the sixth configuration.

Abstract: A method for compliance with Know Your Customer (KYC) and other regulations includes a pseudonymous globally unique identifier stored on a blockchain that associates a pseudonymous first party address with a globally unique identifier representing the vetted identity of the owner of the address. The method also includes a trusted third party issuing a verifiable credential for a first pseudonymous party to a proposed transaction to a second pseudonymous party to the transaction.

Abstract: Various embodiments of the present technology generally relate to systems and methods for providing an interface to securely handle messages from 5G services for network monitoring purposes. In an example, a packet encoder is provided as an interface handler. The packet encoder may receive from one or more network functions (NFs) in a communication exchange on a 5G network, an input including a plurality of messages. Upon receipt, the packet encoder may determine an input format from the input and determine an output format for a feed generated based on the plurality of messages. The packet encoder may also translate the plurality of messages from the input format to the output format, where the input format is different than the output format, and the feed includes the plurality of messages in the output format. The packet encoder may then transmit the feed to a network monitoring system.

Abstract: Various embodiments of the present technology generally relate to systems and methods for providing an interface to securely handle messages from 5G services for network monitoring purposes. In an example, a network traffic monitoring system is provided as an interface handler. The network traffic monitoring system may receive from a plurality of network functions (NFs) in a communication exchange on a 5G network, a first plurality of messages, determine microservices to apply to the first plurality of messages, and process, by respective microservice modules, the first plurality of messages using the microservices. The network traffic monitoring system may also generate a feed based on processing the first plurality of messages using the microservices and transmit, to a network monitoring system, the feed, where the first plurality of messages is in an input format and the feed is in an output format, the input format being different than the output format.

Abstract: Provided herein are compositions and methods for treating musculoskeletal fibrosis and/or scarring by ablating intracellular signaling through specific cell surface receptors through genetic editing. In some aspects, the compositions and methods are directed to the TGFB1 ligand. In other aspects, the compositions and methods are directed to the TGFB1 receptors (TGFBR1/TGFBR2). In some aspects, the compositions and method are to treat or prevent post-trauma fibrosis and/or scarring. In some aspects, the compositions and method are to treat or prevent postoperative fibrosis and/or scarring. In some aspects, the compositions and method are for treating or preventing localized nociception, inflammation, degeneration, or morphological changes associated with fibrosis and/or scarring.

Abstract: Systems and methods are disclosed for generating interactive user interfaces for evaluating transactions of an organization. For example, a system can be configured to receive transactions for an organization and determine a first subset of the transactions during a trip at a first location that is different from a home location of a consumer. A respective transaction associated with a second location that occurred during the trip is identified. The respective transaction is assigned to the first subset of the of transactions for the trip. A second subset of the transactions of a spending type is determined. A parameter value associated with the spending type is identified. A parameter adjustment is determined. The system is configured to cause a display of a spending type user interface on a client device and receive a selection of a parameter component.

Abstract: This disclosure describes systems and methods that facilitate the generation of recommendations by traversing a graph. Walks that traverse the graph may be initiated from a plurality of different nodes in the node graph. In order to give greater or lesser weight to particular nodes, the walks may have different lengths depending on the nodes from which they are initiated, or an unequal amount of walks may be distributed between nodes from which walks are initiated. A plurality of walks through a node graph may be tracked, and visit counts or scores for nodes in the node graph may be determined. For example, scores may be increased for nodes that are visited by a walk initiated from a first node and a second walk initiated from a second node, or scores may be decreased for nodes that are not visited by a first walk initiated from a first node and a second walk initiated from a second node. Content corresponding to nodes may be recommended based on the scores or visit counts.

Abstract: The present invention relates to multilayer films. In one aspect, a multilayer film comprises a first polyethylene composition having a density of at least 0.965 g/cm3 and as further described herein and a second polyethylene composition having a density of 0.924 g/cm3 to 0.936 g/cm3 and as further described herein, wherein the multilayer film comprises 40 weight percent or less of the first polyethylene composition based on the total weight of the multilayer film.

Abstract: An example apparatus includes: controller circuitry configured to: provide switch signals to capacitive digital to analog converter (C-DAC) circuitry, the C-DAC circuitry including switches; configuring the switches into a third configuration begin an Auto Zero (AZ) phase with a third switch in a closed state; configuring the switches into a fourth configuration to repeat the transition of the third switch to the open state corresponding to a first configuration; configuring the switches into a fifth configuration to repeat the transition of a first switch and a second switch to the open state corresponding to a second configuration; configuring the switches into a sixth configuration to repeat the transition of the third switch to the closed state corresponding to a second configuration; and performing an AZ decision with the switches in the sixth configuration.

Abstract: The present application discloses a novel fusion peptide of IL-2 and IL-33 and its use. It comprises a biologically active domain of Interleukin-2 (IL-2) or a biologically active fragment or homolog thereof, and a biologically active domain of Interleukin-33 (IL-33) or a biologically active fragment or homolog thereof. The two portions can be linked by a linker sequence. The application discloses that combination therapies using IL-2 and IL-33 or a therapy using the IL233 fusion protein are effective in preventing or treating diseases and disorders such as autoimmune diseases and disorders, inflammation, etc. Depending on the subject's disease or disorder, the compositions of the invention are useful for preventing certain symptoms, treating the disease, and alleviating at least some of the symptoms.

Abstract: A bandgap tuneable p-GaN high electron mobility transistor (HEMT) having a structure stacked on a silicon carbide substrate. The device incorporates an indium nitride nucleation layer, followed by an aluminum nitride nucleation layer, and a first aluminum gallium nitride buffer layer. A gallium nitride channel layer is deposited on this stack, with an aluminum source and a drain contact at either end. The bandgap tuneable p-GaN HEMT includes a two-dimensional molybdenum disulfide layer over the channel, covered by a second AlGaN buffer layer. A p-type gallium nitride cap layer and a platinum gate contact complete the structure. This configuration facilitates bandgap tuning and strain engineering, enhancing electron mobility and density in the two-dimensional electron gas region, making it suitable for high-power and high-frequency applications.

Abstract: Disclosed herein are compositions comprising an interleukin-2 (IL-2) having at least 90% identity to SEQ ID NO: 13 and a truncated interleukin-33 (IL-33) comprising a sequence with at least 90% identity to SEQ ID NO: 1. The IL-2 and the truncated IL-33 can be domains of fusion proteins. The compositions or the fusion proteins can be used in methods for treating a disease or disorder, comprising administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising the composition or the fusion protein. The disease or disorder can be an autoimmune disease or disorder, a disease or disorder characterized by inflammation, or a cancer.

Abstract: A method for compliance with Know Your Customer (KYC) and other regulations includes a pseudonymous globally unique identifier stored on a blockchain that associates a pseudonymous first party address with a globally unique identifier representing the vetted identity of the owner of the address. The method also includes a trusted third party issuing a verifiable credential for a first pseudonymous party to a proposed transaction to a second pseudonymous party to the transaction.

Abstract: A surgical drill bit assembly for use on a surgical drill. The surgical drill bit assembly includes a shank extending between a proximal end and a distal end along an axis. The surgical drill bit assembly also includes a cutting tip portion adjacent to the distal end of the shank. The surgical drill bit assembly also includes a sleeve disposed about at least a portion of the shank. The sleeve includes a non-magnetic material and an identification feature for identifying a configuration of the cutting tip portion. The identification feature includes a magnetic material. The magnetic material is dispersed in the non-magnetic material.

Abstract: An example analog-to-digital converter (ADC) comprising: sample and hold circuitry coupled to an analog input; a first sub-ADC coupled to the sample and hold circuitry; a multiplying digital-to-analog converter (M-DAC) coupled to the first sub-ADC; summation circuitry coupled to the sample and hold circuitry and the M-DAC; an amplifier coupled to the summation circuitry; a second sub-ADC coupled to the amplifier; and reference generation circuitry coupled to the first sub-ADC, the M-DAC, and the second sub-ADC, the reference generation circuitry including: reference voltage circuitry coupled to the M-DAC; a first resistor coupled to the reference voltage circuitry; a second resistor coupled to the first resistor; and a capacitor coupled in parallel to the second resistor by a switch.

Abstract: Systems and methods provide for submission, verification, and validation of one or more code packages associated with provisioning logic for third-party applications. A user may request verification as a publisher and submit a code package for use with a third-party application within a resource provider environment. The code package may be tested and, upon passing, be published to a public repository for discovery and use by other users. The code package may form part of an extension that is integrated into a template that enables automated provisioning of resources and applications.